BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:20251102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Eastern Standard Time TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Eastern Daylight Time TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:PRE-REGISTRATION REQUIREDVenue:Dyker Beach Golf Course1030 86th Street*Brooklyn\, NY 11228(718) 836-9722*Main entrance driveway is at 88t h Street and 7th Avenue\; venue parking lot is at 86th Street and 11th Ave nueFeatured Clinician:Kenneth E. Fleisher\, D.D.S.\, F.A.C.S.Clinical Prof essor\, Department of Oral and Maxillofacial Surgery\, New York University College of DentistrySynopsis:Bone health and maintenance of bone integrit y are important concerns during comprehensive cancer care and management o f osteoporosis. Bisphosphonates and denosumab are antiresorptive medicatio ns widely used for the prevention and treatment of osteoporosis and skelet al complications associated with metastatic cancer and multiple myeloma. M edication-related osteonecrosis of the jaw (MRONJ) related to antiresorpti ve therapy is a condition that has created numerous dilemmas in patient ma nagement and may have a broad health impact. Minimizing the risk of MRONJ is critical\, not only to prevent MRONJ but also to maximize the benefit o f antiresorptive therapy. This case-based presentation will review evidenc e-based data that has led to paradigm shifts for pathogenesis and innovati ve strategies for risk assessment\, prevention and management of MRONJ.Upo n successful completion of this lecture\, attendees will learn:Strategies for diagnosis of MRONJ related to clinical presentation\, imaging and diff erential diagnosis.Risk assessment and prevention related to dental treatm ent: What works and what doesn’t.Recent advances in pathogenesis: What we know today and how this may impact clinical decisions.Strategies for impro ving oral health and function via dentoalveolar surgery\, restorative dent istry and implant surgery.Management options for patients with MRONJ.MCEU - 1 HourFree for all SDDS members Register *Due to a recent ADA systems up grade\, online registration for all meetings is unavailable until further notice. SDDS staff do not have system access during this outage and are un able to register you over the phone. To register for this meeting\, click the "Register" link above or here to be redirected to an RSVP form we have created specifically for this event. Second District Dental Society is a recognized sponsor by the N.Y.S. Education Department\, ADA CERP and the AGD.Unless otherwise stated\, all featured speakers have disclosed that th ey do not have any relevant financial arrangements or affiliations with an y corporate organizations that would constitute a conflict of interest con cerning the continuing education activities stated herein. DTEND:20241115T045900Z DTSTAMP:20260316T093010Z DTSTART:20241114T233000Z LOCATION: SEQUENCE:0 SUMMARY:(BROOKLYN) SDDS November General Membership Meeting: Update for Med ication-Related Osteonecrosis of the Jaws UID:RFCALITEM639092502103321379 X-ALT-DESC;FMTTYPE=text/html:

PRE-REGISTRATION REQUIRED

Venue:
Dyker Beach Golf Course
103 0 86th Street*
Brooklyn\, NY 11228
(718) 836-9722
*Main entra nce driveway is at 88th Street and 7th Avenue\; venue parking lot is at 86 th Street and 11th Avenue

Featured Clinician:
Kenneth E. Fleisher\, D.D.S.\, F.A.C.S.
Clinical Professor\, De partment of Oral and Maxillofacial Surgery\, New York University College o f Dentistry


Synopsis:
Bone health and m aintenance of bone integrity are important concerns during comprehensive c ancer care and management of osteoporosis. Bisphosphonates and denosumab a re antiresorptive medications widely used for the prevention and treatment of osteoporosis and skeletal complications associated with metastatic can cer and multiple myeloma. Medication-related osteonecrosis of the jaw (MRO NJ) related to antiresorptive therapy is a condition that has created nume rous dilemmas in patient management and may have a broad health impact. Mi nimizing the risk of MRONJ is critical\, not only to prevent MRONJ but als o to maximize the benefit of antiresorptive therapy. This case-based prese ntation will review evidence-based data that has led to paradigm shifts fo r pathogenesis and innovative strategies for risk assessment\, prevention and management of MRONJ.

Upon successful completion of this lecture\ , attendees will learn:

  1. Strategies for diagnosis of MRONJ relat ed to clinical presentation\, imaging and differential diagnosis.
  2. Risk assessment and prevention related to dental treatment: What works and what doesn’t.
  3. Recent advances in pathogenesis: What we know today and how this may impact clinical decisions.
  4. Strategies for improv ing oral health and function via dentoalveolar surgery\, restorative denti stry and implant surgery.
  5. Management options for patients with MRO NJ.

MCEU - 1 Hour

Free for all SDDS members

 \;

Register

 \;

*Due to a recent ADA systems upgrade\, online registration for all meetings is unavailable until further notice. SDDS staff do not have system access du ring this outage and are unable to register you over the phone. \;To register for this meeting\, click the "Register" link above or&nbs p\;here \;to be redi rected to an RSVP form we have created specifically for this event. \;

 \;

Second District Dental Society is a recogni zed sponsor by the N.Y.S. Education Department\, ADA CERP and the AGD.


Unless otherwise stated\, all featured speakers have disclosed that they do not have any relevant financial arran gements or affiliations with any corporate organizations that would consti tute a conflict of interest concerning the continuing education activities stated herein.


END:VEVENT END:VCALENDAR